Fare Capital

Fare Capital is an impact investment firm established in 2017 and located in Oegstgeest, Netherlands. The firm specializes in providing funding solutions and private equity investments, with a focus on mentoring small and medium-sized enterprises in the food and healthcare sectors. Through its strategic investments, Fare Capital aims to support the growth and development of businesses that contribute positively to society while achieving financial returns.

The firm's investment strategy centers on early-stage and growth-stage companies, emphasizing sectors such as food and healthcare. By offering both financial support and mentorship, Fare Capital seeks to enhance the operational capabilities and market reach of its portfolio companies. This approach is designed to foster sustainable growth and innovation within these industries.

In 2021, Fare Capital made a notable investment in MyLife Technologies, a Dutch company specializing in nanoporous micro-needle arrays for transdermal delivery of vaccines and drugs. This investment underscores Fare Capital's commitment to supporting innovative solutions in the healthcare sector that have the potential to make a significant societal impact.